clinivation

  • Sign In
  • Contact
  • About
    • What We Do
    • Newsroom
    • Our Partners
    • Events
    • Careers
    • Contact
  • Solutions
    • Business Development
    • Clinical Operations
    • Commercial Operations
    • Health Policy & Reimbursement
    • Medical Affairs
    • Portfolio Management
    • Regulatory Affairs
    • Research & Development
  • Products
    • CareSite
    • ClinicalSuite
    • Cloud
    • Conformity
    • ForeSight
    • Global
    • Prospectus
    • RealWorld
    • RegistrySuite
    • ValueLogic
    • WorldView
  • Services & Support
    • Customer Support
    • Solution Services
    • CRO Services
    • Professional Services
    • Innovation Workshops
  • Resources
    • Data Sheets
  • Customers
    • Customer Success
Home / News / Yudo Group Selects Clinivation to Advance International Market Access Initiatives
clinivation
CONTACT US

Yudo Group Selects Clinivation to Advance International Market Access Initiatives

Global leader in plastics, factory automation, and robotics selects clinivation to advance international market access initiatives.

CAMBRIDGE, MA – September 15, 2014 – Clinivation, Inc., a leading provider of life sciences solutions that deliver the digital advantage to outperform in global development and commercialization, is pleased to announce today that YUDO Group has selected clinivation to advance certain international market access initiatives.

Ever-proliferating and changing global regulations generate complex challenges of execution in global market clearance operations.

Clinivation’s experienced Technology-Enabled CRO Services team understands how to approach and overcome complex development, quality, regulatory, and market access hurdles.

Unlike traditional consulting, Technology-Enabled CRO Services employs domain-specific information technology to achieve a high operational tempo and an operational fluidity that advances to milestones and deliverables with quality and efficiency.

Quotes & Commentary:

“It is an honor and my pleasure to work with the YUDO teams in Korea and in the U.S., and to advance the international market access initiatives,” said clinivation Founder and CEO Joseph Kozikowski, M.D. “I thank Chairman Francis Yu and his team for their leadership and support,” he continued.

Supporting Resources:

For more information on the clinivation’s Technology-Enabled CRO Services, please visit the clinivation CRO Services homepage

For more information on the clinivation Enterprise Solution for On-Demand Global Regulatory Intelligence and Client-Directed Case Research Solutions, please visit the clinivation WorldView homepage

For more information on the clinivation Enterprise Solution for Global Market Clearance Management, please visit the clinivation Global homepage

About YUDO Group:

YUDO Co., Ltd. was the first company in South Korea to succeed in developing the hot runner systems – the core of injection molding. A globally leading company, YUDO was established in 1980.

YUDO Group received the Entrepreneurship Hall of Fame Award from the Industrial Bank of Korea, and the World Class Products Award from Korean Ministry of Trade, Industry, and Energy.

Mr. Francis Yu, YUDO Group Founder, Chairman, and Group President received the Gold Tower Order of Industrial Merit Award- the highest order of merit for the industrial sector in Korea- from the President of Korea.

The YUDO Group is composed of YUDO Co., Ltd., the parent company, and associated companies such as YUDO-STAR AUTOMATION, YUDO-SUNS, and YUDO-ROBOTICS, which handles such businesses as molds for injection molding machines and automation systems. Harnessing the comprehensive strength of the group, YUDO is extensively involved in the entirety of such systems, including peripheral equipment.

YUDO possesses production and sales bases around the world and has installed over 600 Mazak machines.

Share

About clinivation

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

Media Contact

Corporate Communications
irpr@clinivation.com

clinivation, Inc.
Suite 1800
245 First Street
Cambridge, MA 02142
U.S.A.
Phone +1 617‐444‐8500

About

  • What We Do
  • Newsroom
  • Our Partners
  • Events
  • Careers
  • Contact

Solutions

  • Business Development
  • Clinical Operations
  • Commercial Operations
  • Health Policy & Reimbursement
  • Medical Affairs
  • Portfolio Management
  • Regulatory Affairs
  • Research & Development

Products

  • CareSite
  • ClinicalSuite
  • Cloud
  • Conformity
  • ForeSight
  • Global
  • Prospectus
  • RealWorld
  • RegistrySuite
  • ValueLogic
  • WorldView

Services & Support

  • Customer Support
  • Solution Services
  • CRO Services
  • Professional Services
  • Innovation Workshops

Resources

  • Data Sheets

Customers

  • Customer Success
American Flag US: +1 (617) 444‐8500
Contact Us
  • Privacy
  • Terms Of Use
  • Trademarks
  • Site Map

© 2025 · clinivation, INC.

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly
connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions
that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

​